Logo
Contact Us
Banner

Bazedoxifene acetate

Products

Quote Request

Bazedoxifene acetate

Bazedoxifene acetate

Catalog No.: PC0141

Size: 5 mg, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg

Description

Bazedoxifeneacetate (TSE-424acetate) is an oral, non-steroidal selective estrogen receptor modulator. Bazedoxifene acetate also acts as an inhibitor of IL-6/GP130 protein-protein interaction and may be useful in pancreatic cancer research.

Molecular Weight 530.65
Formula C32H38N2O5
CAS No. 198481-33-3
Appearance Solid
Color White to off-white
SMILES CC1=C(C2=CC=C(O)C=C2)N(CC3=CC=C(OCCN4CCCCCC4)C=C3)C5=CC=C(O)C=C51.CC(O)=O
Shipping Room temperature in continental US; may vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
In Vitro Bazedoxifene acetate is a small molecular GP130 inhibitor, which binds to GP130 D1 domain.
Bazedoxifene acetate inhibits STAT3 phosphorylation induced by Il-6 and IL-11 in GP130/STAT3 pathway signaling.
Bazedoxifene acetate (10 μM-20 μM; 2 hours) inhibits STAT3 Phosphorylation Induced by cytokines in human pancreatic cancer cells.
Bazedoxifene acetate (5-20 μM; overnight) induces apoptosis in human pancreatic cancer cells.
Bazedoxifene acetate inhibits STAT3 nuclear translocation induced by IL-6.
Bazedoxifene acetate blocks the cells migration in pancreatic cancer cells by inhibition of GP130.
In Vivo Bazedoxifene acetate (5 mg/kg; i.g.; daily, for 18 days) inhibits Capan-1 tumor growth in mouse model in vivo.
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Logo

As the scientific machine continues to turn, Alfa Cytology is committed to keeping pace. We continue to expand our services and improve our existing resources to help our customers accelerate their research and support their careers.

Company
Our Services
Our Products

Copyright © Alfa Cytology. All rights reserved.